title: The effect of dietary and topical celecoxib on 4-nitroquinoline-1-oxide-induced lingual epithelium alternations in rat.
abstract: OBJECTIVE
  To compare the preventive effect of dietary and topical Celecoxib (CCB), a potent inhibitor of COX-2 on 4-NQO-induced tongue SCC in rat.
  
  
  METHODS
  Fifty male Sprague Dawley adult 3- 3.5 months old rats were used as animal model in this study. The tongue SCC was induced by a daily administration of 30 ppm 4-NQO, in drinking water, for 8 months. The rats in case groups received dietary or topical CCB. Tongue Specimens were prepared for histopathological and immunohistochemical (Ki-67) staining and or TUNEL assay were examined. Values are expressed as mean +/- SEM and analyzed with Npar Kruscal Wallis and one-way ANOVA tests. p < 0.05 was considered significant.
  
  
  RESULTS
  The incidence of tongue precancer lesions, judged by morphological and morhometrical criteria and apoptosis/proliferation ratio, was significantly (p < 0.01) reduced by CCB. The effect of topical CCB use, at high doses, was comparable to the effect of dietary CCB.
  
  
  CONCLUSIONS
  Both topical and dietary CCB have inhibitory effect on 4-NQO induced SCC on tongue. The effect of CCB is probably mediated by suppression of cell proliferation and induction of apoptosis.
authors.affiliation: Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
authors.forename: Maryam
authors.initials: M
authors.lastname: Sohrabi
authors.forename: Jafar
authors.initials: J
authors.lastname: Soleimani
authors.forename: Leila
authors.initials: L
authors.lastname: Roshangar
authors.forename: Seda
authors.initials: S
authors.lastname: Vatansever
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Arbabi
authors.forename: Amir Afshin
authors.initials: AA
authors.lastname: Khaki
authors.forename: Mehran Mesgari
authors.initials: MM
authors.lastname: Abbasi
authors.forename: Yosuf
authors.initials: Y
authors.lastname: Dustar
authors.forename: Yosuf
authors.initials: Y
authors.lastname: Javadzadeh
mesh_terms: D015112:4-Nitroquinoline-1-oxide; D000287:Administration, Topical; D000704:Analysis of Variance; D000818:Animals; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D004032:Diet; D004195:Disease Models, Animal; D020287:In Situ Nick-End Labeling; D008297:Male; D011230:Precancerous Conditions / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D011720:Pyrazoles / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology*; D014059:Tongue / Q000187:drug effects* / Q000473:pathology; D014062:Tongue Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*
chemical_list: D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D015112:4-Nitroquinoline-1-oxide; D000068579:Celecoxib